Active, Not Recruiting
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
NCT04006210
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Xenoscience Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Cedar- Sinai Medical Center Department of Neurology Los Angeles, California, United States
- SC3 Research - Reseda Reseda, California, United States